Purchases and Sales Made in Q3 2024 in Ab Cellera Biologics Inc. (ABCL)
This table provides information about the institutional ownership of Ab Cellera Biologics Inc. (ABCL) during Q3 2024. The information is specifically focused on institutions that hold shares of AbCellera Biologics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 12, 2024
Q3 2024
|
Citigroup Inc
|
SELL
|
- |
-74.1K- 93.4% |
$177K - $258K
|
5.23K
$15.4K
|
|
|
Nov 14, 2024
Q3 2024
|
Pdt Partners, LLC
New York, NY |
SELL
|
- |
-174K- 73.0% |
$416K - $607K
|
64.3K
$190K
|
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-201K- 63.9% |
$481K - $702K
|
114K
$335K
|
|
|
Nov 13, 2024
Q3 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-443K- 16.26% |
$1.06M - $1.55M
|
2.28M
$6.73M
|
|
|
Nov 05, 2024
Q3 2024
|
Baillie Gifford & CO
|
SELL
|
- |
-9.02M- 41.15% |
$21.5M - $31.5M
|
12.9M
$38M
|